Financial Snapshot

Revenue
$2.384M
TTM
Gross Margin
97.6%
TTM
Net Earnings
-$32.35M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
26.49%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$7.686M
Q3 2024
Cash
Q3 2024
P/E
-0.6030
Dec 04, 2024 EST
Free Cash Flow
-$25.59M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $4.490M $4.854M $1.468M -$188.6K $118.0K $60.30M $67.13M $44.72M $0.00 $12.95M $0.00 $10.00K $70.00K $1.480M $14.18M $11.35M $11.48M $14.41M $19.75M $17.96M $2.320M $1.270M $280.0K $1.790M $5.120M $610.0K $30.00K $720.0K $20.00K $100.0K
YoY Change -7.49% 230.53% -878.61% -259.84% -99.8% -10.18% 50.11% -100.0% -100.0% -85.71% -95.27% -89.56% 24.93% -1.13% -20.33% -27.04% 9.97% 674.14% 82.68% 353.57% -84.36% -65.04% 739.34% 1933.33% -95.83% 3500.0% -80.0% -33.33%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $4.490M $4.854M $1.468M -$188.6K $118.0K $60.30M $67.13M $44.72M $0.00 $12.95M $0.00 $10.00K $70.00K $1.480M $14.18M $11.35M $11.48M $14.41M $19.75M $17.96M $2.320M $1.270M $280.0K $1.790M $5.120M $610.0K $30.00K $720.0K $20.00K $100.0K
Cost Of Revenue $97.64K $420.0K $217.5K $147.8K $0.00 $0.00 $2.340M $860.0K $0.00 $0.00
Gross Profit $4.392M $4.440M $1.251M -$336.4K $11.48M $14.41M $17.41M $17.09M $2.320M $1.270M
Gross Profit Margin 97.83% 91.48% 85.19% 100.0% 100.0% 88.15% 95.16% 100.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Selling, General & Admin $12.27M $15.29M $16.51M $17.34M $9.765M $9.699M $8.642M $9.610M $6.179M $5.678M $4.960M $5.070M $5.050M $4.750M $4.900M $5.300M $6.930M $7.290M $6.840M $7.460M $5.740M $4.870M $5.000M $3.030M $4.570M $3.960M $2.990M $2.530M $1.250M $780.0K
YoY Change -19.76% -7.4% -4.76% 77.53% 0.68% 12.23% -10.07% 55.53% 8.83% 14.47% -2.17% 0.4% 6.32% -3.06% -7.55% -23.52% -4.94% 6.58% -8.31% 29.97% 17.86% -2.6% 65.02% -33.7% 15.4% 32.44% 18.18% 102.4% 60.26% -17.02%
% of Gross Profit 279.34% 344.39% 1319.98% 60.37% 50.59% 39.29% 43.65% 247.41% 383.46%
Research & Development $22.40M $22.63M $21.33M $12.93M $13.96M $14.86M $32.57M $45.68M $43.07M $24.56M $10.83M $10.53M $13.81M $10.38M $12.29M $13.36M $21.19M $36.91M $41.01M $25.05M $23.33M $17.44M $12.12M $10.11M $9.110M $8.720M $7.110M $3.410M $870.0K $620.0K
YoY Change -1.02% 6.11% 64.99% -7.4% -6.04% -54.38% -28.71% 6.06% 75.37% 126.78% 2.85% -23.75% 33.04% -15.54% -8.01% -36.95% -42.59% -10.0% 63.71% 7.37% 33.77% 43.89% 19.88% 10.98% 4.47% 22.64% 108.5% 291.95% 40.32% 5.08%
% of Gross Profit 509.97% 509.7% 1704.93% 184.58% 256.14% 235.55% 146.58% 1005.6% 1373.23%
Depreciation & Amortization $339.1K $290.0K $126.7K $51.12K $64.20K $58.64K $56.57K $33.05K $43.05K $117.6K $110.0K $110.0K $950.0K $1.140M $1.270M $1.370M $1.390M $1.450M $1.260M $1.080M $670.0K $580.0K $1.160M $290.0K $250.0K $230.0K $230.0K $70.00K $70.00K $90.00K
YoY Change 16.92% 128.94% 147.79% -20.37% 9.48% 3.66% 71.16% -23.23% -63.39% 6.9% 0.0% -88.42% -16.67% -10.24% -7.3% -1.44% -4.14% 15.08% 16.67% 61.19% 15.52% -50.0% 300.0% 16.0% 8.7% 0.0% 228.57% 0.0% -22.22% 12.5%
% of Gross Profit 7.72% 6.53% 10.13% 12.11% 10.06% 7.24% 6.32% 28.88% 45.67%
Operating Expenses $26.99M $37.31M $38.06M $30.26M $23.72M $24.56M $41.21M $55.29M $49.25M $30.24M $15.79M $15.60M $18.86M $15.13M $17.20M $18.65M $28.12M $44.21M $47.86M $32.51M $29.07M $22.31M $17.12M $13.13M $13.68M $12.68M $10.10M $5.940M $2.120M $1.400M
YoY Change -27.68% -1.96% 25.75% 27.56% -3.39% -40.41% -25.47% 12.27% 62.88% 91.5% 1.22% -17.29% 24.65% -12.03% -7.77% -33.68% -36.39% -7.63% 47.22% 11.83% 30.3% 30.32% 30.39% -4.02% 7.89% 25.54% 70.03% 180.19% 51.43% -7.89%
Operating Profit -$22.50M -$32.46M -$36.59M -$30.60M -$16.64M -$29.80M -$30.45M -$15.42M -$26.75M -$21.04M
YoY Change -30.69% -11.29% 19.57% -44.16% -2.13% 97.47% -42.36% 27.14%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Interest Expense $17.11K $20.01K $29.68K -$212.4K $1.181M $28.71K -$1.141M -$2.262M -$2.463M -$910.9K $10.00K -$7.030M $20.00K $210.0K $130.0K $210.0K $960.0K $1.270M $830.0K $470.0K $200.0K $230.0K $310.0K $780.0K $380.0K $60.00K $180.0K -$80.00K -$460.0K -$340.0K
YoY Change -14.49% -32.58% -113.98% -117.99% 4012.71% -102.52% -49.54% -8.15% 170.36% -9209.2% -100.14% -35250.0% -90.48% 61.54% -38.1% -78.13% -24.41% 53.01% 76.6% 135.0% -13.04% -25.81% -60.26% 105.26% 533.33% -66.67% -325.0% -82.61% 35.29% 78.95%
% of Operating Profit
Other Income/Expense, Net $696.9K $242.0K $390.1K -$212.4K $0.00 $0.00 -$630.0K $0.00
YoY Change 187.98% -37.97% -283.69% -100.0% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Pretax Income -$29.74M -$32.22M -$36.20M -$33.60M -$22.43M $35.77M $24.79M -$12.83M -$51.71M -$18.20M -$15.77M -$22.62M -$18.32M -$13.45M -$2.790M -$6.540M -$15.68M -$28.53M -$29.63M -$14.94M -$26.56M -$20.81M -$16.53M -$10.56M -$8.180M -$12.00M -$9.890M -$5.300M -$3.900M -$1.640M
YoY Change -7.7% -11.0% 7.74% 49.81% -162.69% 44.33% -293.16% -75.19% 184.18% 15.39% -30.28% 23.47% 36.21% 382.08% -57.34% -58.29% -45.04% -3.71% 98.33% -43.75% 27.63% 25.89% 56.53% 29.1% -31.83% 21.33% 86.6% 35.9% 137.8% 5.81%
Income Tax $0.00 $4.675M $0.00 $0.00 $0.00 $582.5K $500.0K $0.00 -$531.5K -$1.850M -$1.750M -$1.070M -$640.0K -$1.000M -$1.740M -$1.290M -$780.0K -$670.0K -$580.0K -$240.0K -$250.0K -$390.0K -$330.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 2.35%
Net Earnings -$29.74M -$27.54M -$36.20M -$33.60M -$22.43M $35.77M $24.70M -$13.33M -$51.71M -$17.67M -$13.93M -$20.86M -$17.25M -$12.82M -$1.790M -$4.800M -$14.39M -$27.75M -$28.96M -$14.36M -$26.32M -$20.57M -$16.14M -$10.60M -$8.180M -$12.00M -$9.890M -$5.300M -$3.900M -$1.640M
YoY Change 7.97% -23.91% 7.74% 49.81% -162.69% 44.81% -285.3% -74.22% 192.73% 26.82% -33.22% 20.93% 34.56% 616.2% -62.71% -66.64% -48.14% -4.18% 101.67% -45.44% 27.95% 27.45% 52.26% 29.58% -31.83% 21.33% 86.6% 35.9% 137.8% 5.81%
Net Earnings / Revenue -662.26% -567.44% -2465.06% -19006.71% 59.32% 36.8% -29.81% -136.4% -208600.0% -24642.86% -866.22% -12.62% -42.29% -125.35% -192.57% -146.63% -79.96% -1134.48% -1619.69% -5764.29% -592.18% -159.77% -1967.21% -32966.67% -736.11% -19500.0% -1640.0%
Basic Earnings Per Share -$2.02 -$2.21
Diluted Earnings Per Share -$2.02 -$2.53 -$3.793M -$142.0K -$95.56K $164.8K $119.3K -$72.42K -$330.3K -$146.0K -$130.6K -$213.7K -$494.3K -$638.4K -$181.5K -$555.6K -$1.689M -$3.642M -$4.795M -$2.664M -$5.518M -$7.243M -$11.37M -$10.50M -$11.05M -$20.34M -$30.91M -$18.28M -$65.00M -$54.67M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Cash & Short-Term Investments $9.527M $11.00M $29.94M $60.10M $82.85M $43.51M $38.00M $40.45M $9.383M $27.30M $12.20M $24.40M $3.800M $18.90M $8.900M $7.800M $12.80M $33.80M $30.70M $18.10M $20.40M $18.40M $7.900M $11.50M $5.400M $2.800M $4.300M $12.80M $6.800M $500.0K
YoY Change -13.39% -63.26% -50.19% -27.46% 90.42% 14.5% -6.06% 331.09% -65.63% 123.76% -50.0% 542.11% -79.89% 112.36% 14.1% -39.06% -62.13% 10.1% 69.61% -11.27% 10.87% 132.91% -31.3% 112.96% 92.86% -34.88% -66.41% 88.24% 1260.0%
Cash & Equivalents $9.527M $8.000M $29.94M $60.10M $82.85M $43.51M $38.00M $40.20M $8.003M $27.30M $12.20M $19.20M $3.800M $18.90M $5.400M $4.400M $9.400M $31.40M $28.30M $15.70M $17.90M $14.30M $7.900M $11.50M $3.200M $2.300M $4.300M $12.80M $6.800M $500.0K
Short-Term Investments $0.00 $3.000M $0.00 $249.8K $1.381M $0.00 $5.200M $0.00 $0.00 $3.500M $3.400M $3.400M $2.300M $2.300M $2.400M $2.500M $4.100M $1.200M $0.00 $2.200M $500.0K $0.00
Other Short-Term Assets $242.3K $1.900M $1.932M $3.060M $738.2K $637.3K $513.7K $1.011M $1.314M $1.897M $200.0K $300.0K $900.0K $300.0K $400.0K $500.0K $500.0K $1.000M $1.500M $1.900M $400.0K $400.0K $400.0K $200.0K $200.0K $100.0K $500.0K $200.0K $100.0K $0.00
YoY Change -87.25% -1.68% -36.84% 314.47% 15.84% 24.06% -49.2% -23.03% -30.73% 848.38% -33.33% -66.67% 200.0% -25.0% -20.0% 0.0% -50.0% -33.33% -21.05% 375.0% 0.0% 0.0% 100.0% 0.0% 100.0% -80.0% 150.0% 100.0%
Inventory $0.00 $500.0K $944.5K $1.162M $0.00 $1.400M $0.00
Prepaid Expenses
Receivables $0.00 $2.900M $1.780M $1.580M $0.00 $60.27M $0.00 $15.12M $0.00 $0.00 $100.0K $0.00 $500.0K $0.00 $600.0K $100.0K $5.400M $0.00 $0.00 $1.000M $0.00 $0.00 $100.0K $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $9.770M $16.30M $34.60M $65.91M $83.59M $104.4M $38.51M $56.58M $10.70M $29.20M $12.30M $24.70M $4.700M $19.30M $9.300M $8.800M $13.30M $35.40M $32.20M $26.80M $20.80M $18.80M $8.300M $11.70M $6.500M $2.900M $4.800M $13.10M $6.900M $500.0K
YoY Change -40.06% -52.88% -47.51% -21.15% -19.94% 171.11% -31.93% 428.91% -63.36% 137.37% -50.2% 425.53% -75.65% 107.53% 5.68% -33.83% -62.43% 9.94% 20.15% 28.85% 10.64% 126.51% -29.06% 80.0% 124.14% -39.58% -63.36% 89.86% 1280.0%
Property, Plant & Equipment $915.7K $1.600M $1.418M $1.333M $1.406M $141.5K $164.0K $198.2K $97.80K $123.2K $200.0K $300.0K $300.0K $1.300M $2.400M $3.700M $5.100M $6.100M $6.300M $6.500M $2.900M $3.400M $2.400M $1.900M $1.600M $1.500M $1.600M $900.0K $100.0K $100.0K
YoY Change -42.77% 12.85% 6.39% -5.24% 893.61% -13.72% -17.21% 102.61% -20.59% -38.42% -33.33% 0.0% -76.92% -45.83% -35.14% -27.45% -16.39% -3.17% -3.08% 124.14% -14.71% 41.67% 26.32% 18.75% 6.67% -6.25% 77.78% 800.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.200M $0.00
YoY Change
Other Assets $56.92K $100.0K $56.92K $56.92K $56.92K $179.9K $338.9K $56.92K $63.21K $155.3K $100.0K $100.0K $300.0K $600.0K $700.0K $700.0K $700.0K $1.300M $1.500M $1.900M $600.0K $500.0K $500.0K $700.0K $800.0K $300.0K $200.0K
YoY Change -43.08% 75.69% 0.0% 0.0% -68.36% -46.91% 495.43% -9.95% -59.29% 55.28% 0.0% -66.67% -50.0% -14.29% 0.0% 0.0% -46.15% -13.33% -21.05% 216.67% 20.0% 0.0% -28.57% -12.5% 166.67% 50.0%
Total Long-Term Assets $972.6K $1.600M $1.475M $1.390M $1.463M $321.5K $503.0K $255.1K $161.0K $278.4K $300.0K $400.0K $700.0K $1.900M $3.100M $4.400M $5.800M $7.400M $7.800M $8.400M $3.600M $3.900M $4.100M $2.500M $2.400M $1.800M $1.700M $1.000M $100.0K $500.0K
YoY Change -39.21% 8.5% 6.13% -5.04% 355.19% -36.09% 97.18% 58.42% -42.17% -7.19% -25.0% -42.86% -63.16% -38.71% -29.55% -24.14% -21.62% -5.13% -7.14% 133.33% -7.69% -4.88% 64.0% 4.17% 33.33% 5.88% 70.0% 900.0% -80.0%
Total Assets $10.74M $17.90M $36.07M $67.30M $85.05M $104.7M $39.02M $56.83M $10.86M $29.47M $12.60M $25.10M $5.400M $21.20M $12.40M $13.20M $19.10M $42.80M $40.00M $35.20M $24.40M $22.70M $12.40M $14.20M $8.900M $4.700M $6.500M $14.10M $7.000M $1.000M
YoY Change
Accounts Payable $4.102M $4.300M $3.158M $640.7K $715.7K $504.8K $2.224M $1.551M $713.9K $1.106M $300.0K $300.0K $300.0K $500.0K $200.0K $200.0K $600.0K $1.100M $3.100M $4.800M $2.000M $1.300M $1.600M $1.100M $1.000M $1.100M $500.0K $300.0K $200.0K $300.0K
YoY Change -4.61% 36.18% 392.88% -10.48% 41.78% -77.3% 43.34% 117.31% -35.48% 268.83% 0.0% 0.0% -40.0% 150.0% 0.0% -66.67% -45.45% -64.52% -35.42% 140.0% 53.85% -18.75% 45.45% 10.0% -9.09% 120.0% 66.67% 50.0% -33.33%
Accrued Expenses $4.566M $6.900M $7.246M $6.149M $3.212M $2.849M $2.103M $10.52M $7.768M $6.223M $1.500M $1.700M $3.100M $2.200M $2.200M $1.400M $2.400M $3.400M $5.300M $4.500M $2.700M $2.000M $1.300M $1.000M $1.000M $1.300M $1.100M $1.500M $700.0K $300.0K
YoY Change -33.83% -4.78% 17.84% 91.45% 12.75% 35.46% -80.01% 35.45% 24.81% 314.9% -11.76% -45.16% 40.91% 0.0% 57.14% -41.67% -29.41% -35.85% 17.78% 66.67% 35.0% 53.85% 30.0% 0.0% -23.08% 18.18% -26.67% 114.29% 133.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.100M $1.000M
YoY Change -100.0% 10.0%
Long-Term Debt Due $46.01K $100.0K $100.9K $0.00 $332.9K $5.949M $7.839M $5.402M $25.87K $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $300.0K $200.0K $100.0K $0.00 $0.00 $200.0K $0.00 $0.00 $900.0K $1.000M $300.0K $100.0K
YoY Change -53.99% -0.91% -100.0% -94.4% -24.12% 45.11% 20782.8% -100.0% -66.67% 50.0% 100.0% -100.0% -100.0% -10.0% 233.33% 200.0%
Total Short-Term Liabilities $9.658M $15.10M $16.26M $10.51M $3.928M $4.186M $10.76M $54.96M $13.88M $7.356M $2.800M $2.100M $3.500M $2.800M $2.400M $8.700M $5.000M $9.600M $12.40M $13.00M $5.000M $4.000M $3.700M $2.300M $2.000M $2.400M $2.500M $2.700M $2.400M $1.700M
YoY Change -36.04% -7.13% 54.68% 167.64% -6.17% -61.11% -80.42% 295.87% 88.75% 162.71% 33.33% -40.0% 25.0% 16.67% -72.41% 74.0% -47.92% -22.58% -4.62% 160.0% 25.0% 8.11% 60.87% 15.0% -16.67% -4.0% -7.41% 12.5% 41.18%
Long-Term Debt $0.00 $0.00 $152.4K $0.00 $0.00 $0.00 $332.9K $6.282M $14.12M $9.823M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $300.0K $200.0K $0.00 $0.00 $100.0K $0.00 $0.00 $0.00 $2.000M $0.00 $900.0K $1.800M $2.100M
YoY Change -100.0% -100.0% -94.7% -55.52% 43.76% -100.0% -66.67% 50.0% -100.0% -100.0% -100.0% -50.0% -14.29%
Other Long-Term Liabilities $1.196M $2.600M $3.391M $7.133M $953.4K $0.00 $956.0K $754.0K $439.1K $91.30K $0.00 $0.00 $100.0K $100.0K $700.0K $1.200M $7.500M $14.40M $9.100M $12.90M $3.000M $0.00 $0.00 $0.00 $0.00 $600.0K $600.0K $0.00
YoY Change -54.0% -23.32% -52.47% 648.25% -100.0% 26.8% 71.69% 380.97% -100.0% 0.0% -85.71% -41.67% -84.0% -47.92% 58.24% -29.46% 330.0% -100.0% 0.0%
Total Long-Term Liabilities $1.196M $2.600M $3.543M $7.133M $953.4K $0.00 $1.289M $7.036M $14.56M $9.914M $0.00 $0.00 $100.0K $100.0K $700.0K $1.200M $7.600M $14.70M $9.300M $12.90M $0.00 $100.0K $0.00 $0.00 $0.00 $2.000M $600.0K $1.500M $1.800M $2.100M
YoY Change -54.0% -26.62% -50.33% 648.25% -100.0% -81.68% -51.68% 46.86% -100.0% 0.0% -85.71% -41.67% -84.21% -48.3% 58.06% -27.91% -100.0% -100.0% 233.33% -60.0% -16.67% -14.29%
Total Liabilities $10.85M $17.80M $19.80M $17.65M $4.881M $4.186M $12.05M $62.00M $28.44M $17.27M $2.800M $2.100M $3.500M $3.000M $3.100M $9.900M $12.60M $24.30M $21.70M $25.90M $5.000M $4.100M $3.700M $2.300M $2.000M $4.400M $3.100M $4.200M $4.200M $3.800M
YoY Change -39.02% -10.11% 12.23% 261.52% 16.6% -65.27% -80.56% 117.96% 64.7% 516.79% 33.33% -40.0% 16.67% -3.23% -68.69% -21.43% -48.15% 11.98% -16.22% 418.0% 21.95% 10.81% 60.87% 15.0% -54.55% 41.94% -26.19% 0.0% 10.53%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Basic Shares Outstanding 14.70M shares 10.89M shares
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $19.509 Million

About PALATIN TECHNOLOGIES INC

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. The company is headquartered in Cranbury, New Jersey and currently employs 30 full-time employees. The firm is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor system. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its new product development activities focus primarily on MC1r agonists, with the potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. The company is also developing peptides that are active at more than one melanocortin receptor, and MC4r peptide and small molecule agonists with potential utility in obesity and metabolic-related disorders, including rare disease and orphan indications. Its product candidates include PL9643 for dry eye disease and PL8177 for the treatment of ulcerative colitis.

Industry: Pharmaceutical Preparations Peers: Akebia Therapeutics, Inc. Atreca, Inc. BIOVIE INC. Unity Biotechnology, Inc. Disc Medicine, Inc. GT Biopharma, Inc. EOM Pharmaceutical Holdings, Inc. Surface Oncology, Inc. Solid Biosciences Inc.